The effect of temporarily halting new puberty blocker prescriptions on transgender young people w/ PATHA's Dr Elizabeth McElrea: 24 November, 2025
Description
Recently, the government has announced it will be halting new prescriptions for puberty blockers for young people with gender dysphoria pending a clinical trial in the UK, with the outcome of this trial set for 2031.
Health Minister, Simeon Brown, says this move is a “precautionary” measure, as he says the evidence regarding puberty blockers for young people with gender dysphoria remains unclear.
Despite this, puberty blockers will still be available for young people with conditions such as endometriosis and precocious puberty.
News and Editorial Director and Monday Wire Host Joel spoke to Dr Elizabeth McElrea, the Vice President of PATHA, the Professional Association of Transgender Health Aotearoa and GP specialist in gender-affirming care, about the government's temporary ban of puberty blocker prescriptions for transgender youth, and what this will mean for young people with gender dysphoria.
United States
